overy it has been found to be expressed in numerous tissues, including the lungs and the cardiovascular system (2). During 2020, there has been a renewed interest in this receptor, due to the interactions of novel coronaviruses and their interactions with ACE2 (3–5). South and co-workers in 2020 also investigated whether ACE2 blockade is a suitable option to attenuate COVID-19 (5).